Form 4: HCA Healthcare CEO Samuel Hazen Reports Stock Transactions

HCA Healthcare CEO Samuel Hazen reports acquisition and disposal of company stock on February 13, 2025, according to a Form 4 filing.

Summary

• On February 13, 2025, Samuel Hazen, CEO of HCA Healthcare, reported transactions involving HCA common stock.
• Hazen acquired 13,218 shares of common stock at $0.
• He also disposed of 4,742 shares at a price of $321.92.
• Following these transactions, Hazen directly owns 71,676 shares.
• He also has indirect ownership through various trusts and GRATs, totaling 1,262,672 shares.
• The filing also references performance share units granted on January 28, 2022, which vested based on the company's earnings per share performance for fiscal years 2022-2024.
• The number of performance share units that vested equaled 51.9% of the units granted.

Sentiment

Score: 5

Explanation: The sentiment is neutral as the document primarily reports stock transactions without expressing a clear positive or negative outlook. The acquisition could be seen as positive, while the disposal could be seen as negative.

Positives

• The acquisition of shares by the CEO could be interpreted as a sign of confidence in the company's future performance.

Negatives

• The disposal of shares by the CEO could be interpreted as a lack of confidence in the company's future performance.

Risks

• The vesting of performance share units is dependent on the company's future earnings per share performance, which is subject to various economic and market risks.

Future Outlook

The vesting of future performance share units will depend on the company's ability to meet its earnings per share goals.

Industry Context

Monitoring insider transactions is a common practice in the healthcare industry to gauge executive sentiment and potential future performance.

Comparison to Industry Standards

• Comparing Samuel Hazen's transactions to those of CEOs at similar healthcare companies like Universal Health Services or Tenet Healthcare could provide insights into industry trends.
• Analyzing the vesting criteria for performance share units against industry benchmarks can reveal how HCA's executive compensation aligns with performance incentives.

Stakeholder Impact

• Shareholders may be interested in the CEO's stock transactions as an indicator of the company's prospects.
• Employees with stock options or performance-based compensation may be affected by the company's earnings per share performance.

Key Dates

Keywords

HCA Healthcare, Samuel Hazen, stock transaction, Form 4, performance share units, beneficial ownership, CEO